Literature DB >> 24627590

Risk factors and outcome of bacterial infections in cirrhosis.

Tony Bruns1, Henning W Zimmermann1, Andreas Stallmach1.   

Abstract

Viable and non-viable pathological bacterial translocation promote a self-perpetuating circle of dysfunctional immune activation and systemic inflammation facilitating infections and organ failure in advanced cirrhosis. Bacterial infections and sepsis are now recognized as a distinct stage in the natural progression of chronic liver disease as they accelerate organ failure and contribute to the high mortality observed in decompensated cirrhosis. The increasing knowledge of structural, immunological and hemodynamic pathophysiology in advanced cirrhosis has not yet translated into significantly improved outcomes of bacterial infections over the last decades. Therefore, early identification of patients at the highest risk for developing infections and infection-related complications is required to tailor the currently available measures of surveillance, prophylaxis and therapy to the patients in need in order to improve the detrimental outcome of bacterial infections in cirrhosis.

Entities:  

Keywords:  Bacterial translocation; Chronic liver disease; Cirrhosis; Immunity; Infection; Mortality; Risk factors

Mesh:

Substances:

Year:  2014        PMID: 24627590      PMCID: PMC3949263          DOI: 10.3748/wjg.v20.i10.2542

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  154 in total

Review 1.  EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.

Authors: 
Journal:  J Hepatol       Date:  2010-06-01       Impact factor: 25.083

2.  Antibiotic prophylaxis for GI endoscopy.

Authors:  Subhas Banerjee; Bo Shen; Todd H Baron; Douglas B Nelson; Michelle A Anderson; Brooks D Cash; Jason A Dominitz; S Ian Gan; M Edwyn Harrison; Steven O Ikenberry; Sanjay B Jagannath; David Lichtenstein; Robert D Fanelli; Ken Lee; Trina van Guilder; Leslie E Stewart
Journal:  Gastrointest Endosc       Date:  2008-03-28       Impact factor: 9.427

3.  NOD2 gene variants are a risk factor for culture-positive spontaneous bacterial peritonitis and monomicrobial bacterascites in cirrhosis.

Authors:  Tony Bruns; Jack Peter; Philipp A Reuken; Dominik H Grabe; Sonja R Schuldes; Julia Brenmoehl; Jürgen Schölmerich; Reiner Wiest; Andreas Stallmach
Journal:  Liver Int       Date:  2011-06-13       Impact factor: 5.828

4.  Intestinal permeability in liver cirrhosis: relationship with severe septic complications.

Authors:  B Campillo; P Pernet; P N Bories; J P Richardet; M Devanlay; C Aussel
Journal:  Eur J Gastroenterol Hepatol       Date:  1999-07       Impact factor: 2.566

5.  Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.

Authors:  E Akriviadis; R Botla; W Briggs; S Han; T Reynolds; O Shakil
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

6.  Analysis of T cell activation pathways in patients with liver cirrhosis, impaired delayed hypersensitivity and other T cell-dependent functions.

Authors:  C A Schirren; M C Jung; R Zachoval; H Diepolder; R Hoffmann; G Riethmüller; G R Pape
Journal:  Clin Exp Immunol       Date:  1997-04       Impact factor: 4.330

7.  Microbiology of bacterial translocation in humans.

Authors:  C J O'Boyle; J MacFie; C J Mitchell; D Johnstone; P M Sagar; P C Sedman
Journal:  Gut       Date:  1998-01       Impact factor: 23.059

8.  Ammonia impairs neutrophil phagocytic function in liver disease.

Authors:  Debbie L Shawcross; Gavin A K Wright; Vanessa Stadlbauer; Stephen J Hodges; Nathan A Davies; Caroline Wheeler-Jones; Andrew A Pitsillides; Rajiv Jalan
Journal:  Hepatology       Date:  2008-10       Impact factor: 17.425

9.  Influence of cephalosporines III generation with varying biliary excretion on fecal flora and emergence of resistant bacteria during and after cessation of therapy.

Authors:  J P Guggenbichler; F J Allerberger; M Dierich
Journal:  Padiatr Padol       Date:  1986

10.  Plasma interleukin-6 levels in patients with cirrhosis. Relationship to endotoxemia, tumor necrosis factor-alpha, and hyperdynamic circulation.

Authors:  F Y Lee; R H Lu; Y T Tsai; H C Lin; M C Hou; C P Li; T M Liao; L F Lin; S S Wang; S D Lee
Journal:  Scand J Gastroenterol       Date:  1996-05       Impact factor: 2.423

View more
  49 in total

1.  Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications.

Authors:  Georgios I Tsiaoussis; Stelios F Assimakopoulos; Athanassios C Tsamandas; Christos K Triantos; Konstantinos C Thomopoulos
Journal:  World J Hepatol       Date:  2015-08-18

2.  Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update.

Authors:  Shiv Kumar Sarin; Ashok Choudhury; Manoj K Sharma; Rakhi Maiwall; Mamun Al Mahtab; Salimur Rahman; Sanjiv Saigal; Neeraj Saraf; A S Soin; Harshad Devarbhavi; Dong Joon Kim; R K Dhiman; Ajay Duseja; Sunil Taneja; C E Eapen; Ashish Goel; Q Ning; Tao Chen; Ke Ma; Z Duan; Chen Yu; Sombat Treeprasertsuk; S S Hamid; Amna S Butt; Wasim Jafri; Akash Shukla; Vivek Saraswat; Soek Siam Tan; Ajit Sood; Vandana Midha; Omesh Goyal; Hasmik Ghazinyan; Anil Arora; Jinhua Hu; Manoj Sahu; P N Rao; Guan H Lee; Seng G Lim; Laurentius A Lesmana; Cosmas Rinaldi Lesmana; Samir Shah; V G Mohan Prasad; Diana A Payawal; Zaigham Abbas; A Kadir Dokmeci; Jose D Sollano; Gian Carpio; Ananta Shresta; G K Lau; Md Fazal Karim; Gamal Shiha; Rino Gani; Kemal Fariz Kalista; Man-Fung Yuen; Seema Alam; Rajeev Khanna; Vikrant Sood; Bikrant Bihari Lal; Viniyendra Pamecha; Ankur Jindal; V Rajan; Vinod Arora; Osamu Yokosuka; Madunil A Niriella; Hai Li; Xiaolong Qi; Atsushi Tanaka; Satoshi Mochida; Dominic Ray Chaudhuri; Ed Gane; Khin Maung Win; Wei Ting Chen; Mohd Rela; Dharmesh Kapoor; Amit Rastogi; Pratibha Kale; Archana Rastogi; Chhagan Bihari Sharma; Meenu Bajpai; Virender Singh; Madhumita Premkumar; Sudhir Maharashi; A Olithselvan; Cyriac Abby Philips; Anshu Srivastava; Surender K Yachha; Zeeshan Ahmad Wani; B R Thapa; Anoop Saraya; Ashish Kumar; Manav Wadhawan; Subash Gupta; Kaushal Madan; Puja Sakhuja; Vivek Vij; Barjesh C Sharma; Hitendra Garg; Vishal Garg; Chetan Kalal; Lovkesh Anand; Tanmay Vyas; Rajan P Mathur; Guresh Kumar; Priyanka Jain; Samba Siva Rao Pasupuleti; Yogesh K Chawla; Abhijit Chowdhury; Shahinul Alam; Do Seon Song; Jin Mo Yang; Eileen L Yoon
Journal:  Hepatol Int       Date:  2019-06-06       Impact factor: 6.047

3.  Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014.

Authors:  Shiv Kumar Sarin; Chandan Kumar Kedarisetty; Zaigham Abbas; Deepak Amarapurkar; Chhagan Bihari; Albert C Chan; Yogesh Kumar Chawla; A Kadir Dokmeci; Hitendra Garg; Hasmik Ghazinyan; Saeed Hamid; Dong Joon Kim; Piyawat Komolmit; Suman Lata; Guan Huei Lee; Laurentius A Lesmana; Mamun Mahtab; Rakhi Maiwall; Richard Moreau; Qin Ning; Viniyendra Pamecha; Diana Alcantara Payawal; Archana Rastogi; Salimur Rahman; Mohamed Rela; Anoop Saraya; Didier Samuel; Vivek Saraswat; Samir Shah; Gamal Shiha; Brajesh Chander Sharma; Manoj Kumar Sharma; Kapil Sharma; Amna Subhan Butt; Soek Siam Tan; Chitranshu Vashishtha; Zeeshan Ahmed Wani; Man-Fung Yuen; Osamu Yokosuka
Journal:  Hepatol Int       Date:  2014-09-26       Impact factor: 6.047

4.  Acute Kidney Injury in Cirrhosis: Baseline Serum Creatinine Predicts Patient Outcomes.

Authors:  F Wong; J G O'Leary; K R Reddy; G Garcia-Tsao; M B Fallon; S W Biggins; R M Subramanian; P J Thuluvath; P S Kamath; H Patton; B Maliakkal; P Tandon; H Vargas; L Thacker; J S Bajaj
Journal:  Am J Gastroenterol       Date:  2017-04-25       Impact factor: 10.864

Review 5.  Alcohol abuse and disorder of granulopoiesis.

Authors:  Xin Shi; Angelo L DeLucia; Jianxin Bao; Ping Zhang
Journal:  Pharmacol Ther       Date:  2019-03-01       Impact factor: 12.310

Review 6.  Liver - guardian, modifier and target of sepsis.

Authors:  Pavel Strnad; Frank Tacke; Alexander Koch; Christian Trautwein
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-12-07       Impact factor: 46.802

Review 7.  Acute-on-chronic Liver Failure.

Authors:  Shiv Kumar Sarin; Ashok Choudhury
Journal:  Curr Gastroenterol Rep       Date:  2016-12

8.  Infective endocarditis in patients with hepatic diseases.

Authors:  E Seminari; A De Silvestri; V Ravasio; S Ludovisi; R Utili; N Petrosillo; F Castelli; M Bassetti; F Barbaro; P Grossi; N Barzaghi; M Rizzi; L Minoli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-12-21       Impact factor: 3.267

Review 9.  Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management.

Authors:  Sara Blasco-Algora; José Masegosa-Ataz; María Luisa Gutiérrez-García; Sonia Alonso-López; Conrado M Fernández-Rodríguez
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

10.  Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.

Authors:  Yun-Xia Chen; Li-Na Lai; Hui-Ying Zhang; Yang-Hui Bi; Li Meng; Xu-Jiong Li; Xiao-Xia Tian; Li-Min Wang; Yi-Min Fan; Zhong-Fu Zhao; De-Wu Han; Cheng Ji
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.